People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PaxMedica, Inc. | — | Biotechnology | Seed | $4.2M | $18.7M | 2022 |
| Visiox Pharma, LLC | — | Pharmaceuticals | Seed | $1.3M | $17.5M | 2022 |
Zachary Rome at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Zachary Rome on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Derby | 2 | 5 |
| HOWARD WEISMAN | 1 | 3 |
| Karen LaRochelle | 1 | 1 |
| Robert K. Apple | 1 | 1 |
| Paul K. Wotton, Ph. D. | 1 | 1 |
| Karen J. LaRochelle | 1 | 1 |
| Karen J. Dawes | 1 | 1 |
| Zachary J. Rome | 1 | 1 |
| Joseph J. Lucchese | 1 | 1 |
| Howard J. Weisman | 1 | 1 |
| Michael J. Derby | 1 | 1 |
| Ryan Bleeks | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.